Rita Banzi

The revised Cochrane risk of bias tool for randomized trials (RoB 2) showed low interrater reliability and challenges in its application

Silvia Minozzi, Michela Cinquini, Silvia Gianola et al. · Journal of Clinical Epidemiology · 2020 · 455 citations

Public Health, Biostatistics, Evidence-based Practice +13

Sharing and reuse of individual participant data from clinical trials: principles and recommendations

Christian Ohmann, Rita Banzi, Steve Canham et al. · BMJ Open · 2017 · 205 citations · Full text

Computing, Clinical Sciences, Health Informatics +17

Nilvadipine in mild to moderate Alzheimer disease: A randomised controlled trial

Brian Lawlor, Ricardo Segurado, Seán Kennelly et al. · PLoS Medicine · 2018 · 202 citations · Full text

Medicine, Neurology, Pharmacology +17

Conceptual frameworks and empirical approaches used to assess the impact of health research: an overview of reviews

Rita Banzi, Lorenzo Moja, Vanna Pistotti et al. · Health Research Policy and Systems · 2011 · 159 citations · Full text

Public Affairs, Health Policy, Health Economics +16

Propidium-Based Polyamine Ligands as Potent Inhibitors of Acetylcholinesterase and Acetylcholinesterase-Induced Amyloid-β Aggregation

María Laura Bolognesi, Vincenza Andrisano, Manuela Bartolini et al. · Journal of Medicinal Chemistry · 2004 · 136 citations · Full text

Life Sciences, Medicinal Chemistry, Pharmacology +17